Got an idea to solve real issues? This challenge offers Rs 1 crore to innovators
Special accolades such as the Goodwill Award, Young Innovator Award, and Social Media Champion will offer another Rs 4.5 lakh in total prize money.EMPOWERING YOUNG INNOVATORS WITH FUNDING, TRAINING AND GLOBAL EXPOSUREParticipants will benefit from over 82,000 hours of mentorship and training in design thinking, go-to-market strategy, and business planning. The top 100 selected teams (25 per theme) will undergo online training, video pitching, and prototyping exercises, with curated visits to Samsung's research and design facilities in Bengaluru, Noida, and Delhi. The top 20 teams will compete in the grand finale, culminating in investor meets, pitch presentations, and an awards ceremony.advertisementJB Park, President & CEO of Samsung Southwest Asia, stated, 'Solve for Tomorrow encourages students across India to become agents of change, supporting the vision of Digital India through tech-led solutions.'Echoing the sentiment, IIT Delhi Director Prof. Rangan Banerjee noted the initiative's potential to nurture impactful ideas into scalable products that benefit society.Global collaborators such as the United Nations and MeitY Startup Hub are also backing the initiative, recognizing its alignment with Sustainable Development Goals and India's 2047 development vision.Launched in the U.S. in 2010, Solve for Tomorrow is now active in 68 countries and has engaged over 3 million youth globally under Samsung's global CSR vision: Together for Tomorrow! Enabling People.Must Watch
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
28 minutes ago
- Indian Express
Jane Street slams Sebi allegations, plans to contest ban and impounding order
New York-based global proprietary trading firm Jane Street has strongly criticised India's market regulator Sebi over its recent enforcement action, calling the accusations 'extremely inflammatory' and stating it is 'beyond disappointed' by the order. The firm, which is among the largest players on Wall Street, said in a mail to its employees that it is preparing a formal response to the Securities and Exchange Board of India's (Sebi) decision, which includes a ban on the firm's market participation and an order to impound Rs 4,843 crore in what the regulator described as 'unlawful gains'. Jane Street rejected the market watchdog's charge that it was involved in 'an intentional, well planned, and sinister scheme' to manipulate Indian markets through its derivatives trades, especially in Nifty Index futures. The firm asserted it would contest the order through appropriate legal channels. In a memo sent to its roughly 3,000 employees on Sunday and reported by the Financial Times newspaper, Jane Street said, 'it's deeply upsetting to see the firm mischaracterised this way.' 'We take pride in the role we serve in markets around the world, and it's painful to have our firm's reputation tarnished by a report based on so many erroneous or unsupported assertions,' the memo said. Jane Street is yet to respond to a mail about the Sebi allegations sent by The Indian Express. Last week, the market regulator granted Jane Street 21 days to file an objection to its order and request a hearing. Jane Street, one of the most prominent and successful proprietary trading firms to emerge in the past two decades, has grown into a major force across global financial markets. In its internal memo, Jane Street criticised Sebi for relying on 'a metric for market impact and trading aggressiveness which seems disconnected from actual market dynamics.' The firm argued that its trading activity on January 17, 2024 — one of the days singled out in Sebi's report — reflected routine 'basic arbitrage trading,' a widely accepted strategy in the industry. Jane Street has sharply contested Sebi's claim that it disregarded concerns raised by the National Stock Exchange (NSE), an allegation the regulator used to justify its sudden and unprecedented ban on the firm's trading operations in India. In the internal memo, Jane Street described the charge as 'especially far from reality,' stating that it had promptly halted its trading activity at the time to better understand the exchange's concerns. The firm added that it subsequently adjusted its strategies to align with the NSE's stated preferences. 'Once again, we left this process feeling that we had reached an understanding of the concerns and reflected them in modifications to our trading behaviour,' the memo said. 'Since February, we have made ongoing efforts to communicate with Sebi and have been consistently rebuffed.' According to the FT report, the US firm nearly doubled its net trading revenues to $20.5 billion last year, outpacing several of Wall Street's biggest banks. In the first quarter of 2025, Jane Street notched up net trading revenues of $7.2 billion, more than Morgan Stanley. 'Sebi's investigation was triggered by revelations from a lawsuit launched by Jane Street last year against Millennium Management and two former traders that had moved to the hedge fund. Jane Street's complaint alleged that the traders had stolen a hugely valuable trading strategy, which was later revealed to revolve around Indian options trading,' FT report said. According to the regulator's findings, Jane Street's trades, particularly in Nifty index futures, showed a clear pattern. The firm wasn't trading passively or reacting to the market — it was nudging prices upward, consistently placing orders at or above the last traded price (LTP). This pattern intensified in the final hours of trading, a critical window that often shapes the day's closing price. Sebi described it as a 'non-neutral trading behaviour', a strategic attempt to influence prices rather than simply engage with the market. And the tactic wasn't random; it followed a well-known play in the trading world: 'marking the close.' Jane Street, regulators say, was executing what's known as an extended 'marking the close' strategy — placing large and aggressive buy or sell orders near the end of the trading session, with the intention of artificially moving the closing price of a stock or index. The closing price is critical, especially on derivatives expiry days, as it determines the settlement value for futures and options contracts.
Time of India
30 minutes ago
- Time of India
Thermal power expansion: Adani Power acquires VIPL for Rs 4,000 crore; capacity hits 18,150 MW
Adani Power acquires VIPL Adani Power Ltd (APL), India's largest private thermal power producer, has completed the acquisition of Vidarbha Industries Power Ltd. (VIPL) for Rs 4,000 crore, further cementing its dominance in the base-load power generation sector. The resolution plan was approved by the National Company Law Tribunal (NCLT), Mumbai Bench, on June 18 and successfully implemented on Monday. As per ANI, VIPL is a 2x300 MW coal-based power plant located at Butibori in Nagpur district, Maharashtra. The plant had been undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code (IBC) prior to this acquisition. Following this addition, Adani Power's total operating capacity has reached 18,150 MW. The company now plans to significantly expand this figure through a combination of brownfield and greenfield ultra-supercritical power projects across the country. APL is currently constructing six brownfield Ultra-supercritical Thermal Power Plants (USCTPP), each of 1,600 MW capacity, across its existing facilities in Singrauli-Mahan (Madhya Pradesh), Raipur, Raigarh, and Korba (Chhattisgarh), and Kawai (Rajasthan). A separate greenfield USCTPP of 1,600 MW is also being developed at Mirzapur in Uttar Pradesh. Additionally, construction of a 1,320 MW Supercritical power plant at Korba, previously acquired by Adani Power, is being revived. With all these projects, APL is targeting to scale up its base-load generation portfolio to 30,670 MW by 2030. Commenting on the development, SB Khyalia, CEO of Adani Power, was quoted as saying by ANI, 'The acquisition of VIPL is a key milestone in Adani Power's strategy to unlock value through the turnaround of stressed assets. As we continue expanding our portfolio, we remain committed to supporting India's vision of 'Electricity for All' by delivering reliable, affordable base-load power that fuels the country's sustainable growth. ' Adani Power operates thermal plants across Gujarat, Maharashtra, Karnataka, Rajasthan, Chhattisgarh, Madhya Pradesh, Jharkhand, and Tamil Nadu. The company also runs a 40 MW solar power plant in Gujarat, contributing to its growing diversification in energy generation. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
30 minutes ago
- Time of India
IIT Delhi announces 6-month online executive programme focused on AI in Healthcare: Check details here
The Indian Institute of Technology (IIT) Delhi, in partnership with TeamLease EdTech, has introduced a comprehensive online executive programme in Artificial Intelligence (AI) in Healthcare, specially designed for working professionals across diverse domains. Scheduled to begin on November 1, 2025, this programme seeks to bridge the gap between healthcare and technology by imparting industry-relevant AI skills to professionals, including doctors, engineers, data scientists, and med-tech entrepreneurs. Applications for the programme are currently open and will remain so until July 31, 2025. Interested professionals are encouraged to submit their applications through the official IIT Delhi CEP portal. This initiative is a part of IIT Delhi 's eVIDYA platform, developed under the Continuing Education Programme (CEP), and aims to foster applied learning through a blend of theoretical instruction and hands-on experience using real clinical datasets. This course offers a unique opportunity to upskill with one of India's premier institutes and contribute meaningfully to the rapidly evolving field of AI-powered healthcare. Programme overview To help prospective applicants plan better, here is a quick summary of the programme's key details: Category Details Course duration November 1, 2025 – May 2, 2026 Class schedule Online and conducted over weekends Programme fee ₹1,20,000 + 18% GST (Payable in two easy installments) Application deadline July 31, 2025 Learning platform IIT Delhi Continuing Education Programme (CEP) portal Who can benefit from this course? The programme is tailored for a wide spectrum of professionals who are either involved in healthcare or aspire to work at the intersection of health and technology. You are an ideal candidate if you are: • A healthcare practitioner or clinician with limited or no background in coding or artificial intelligence, but curious to explore AI's applications in medicine. • An engineer, data analyst, or academic researcher engaged in health-tech innovations or biomedical computing. • A med-tech entrepreneur or healthcare startup founder looking to incorporate AI-driven solutions into your business or products. Curriculum overview Participants will engage with a carefully curated curriculum that balances core concepts with real-world applications. Key modules include: • Introduction to AI, Machine Learning (ML), and Deep Learning (DL) concepts. • How AI is used to predict disease outcomes and assist in clinical decision-making. • Leveraging AI in population health management and epidemiology. • Application of AI for hospital automation and familiarity with global healthcare data standards like FHIR and DICOM. • Over 10 detailed case studies showcasing successful AI applications in hospitals and clinics. • A hands-on project with expert mentorship from faculty at IIT Delhi and clinicians from AIIMS, enabling learners to apply their knowledge to real clinical challenges. Learning outcomes you can expect By the end of this programme, participants will be equipped with the ability to: • Leverage AI technologies to enhance clinical workflows, automate processes, and support evidence-based decision making in healthcare. • Work effectively with diverse data sources such as Electronic Medical Records (EMRs), radiology images, genomics data, and Internet of Things (IoT)-based health devices. • Develop and deploy functional AI models tailored for practical use in hospitals, diagnostics, and public health infrastructure. • Earn a prestigious certification from IIT Delhi, enhancing your professional credentials in the health-tech domain. Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
